不可手术局部晚期非小细胞肺癌根治性放化疗后首次失败模式预测模型
该研究回顾性分析2013–2016年接受根治性放化疗的LA-NSCLC患者,以首次失败为终点,用弹性网回归和5折嵌套交叉验证筛选最优模型并构建列线图,最终模型含9个因素,平均AUC为0.719,校准曲线与DCA显示一定预测价值。
要点
- 100例失败患者中局部失败46例、远处失败54例。
- 最终模型含吸烟、病理、部位、EGFR突变、年龄、肿瘤直径、临床N分期、巩固化疗和放疗剂量9个因素。
- 5折嵌套交叉验证平均AUC为0.719,优于任何单一因素。
核心结论
- 临床病理因素可协同预测LA-NSCLC根治性放化疗后的失败模式,基于这些因素构建并验证的列线图在临床实践中具有潜在预测价值。
研究设计与样本
- 回顾性收集2013至2016年在本院接受根治性放化疗并随访的LA-NSCLC患者临床病理数据,以根治性放化疗后首次失败为终点,采用弹性网回归和5折嵌套交叉验证选择最优模型并构建列线图。
主要发现
- 中位随访28个月,100例患者发生失败,其中局部失败46例、远处失败54例。
- 最终预测模型包含9个因素:吸烟、病理、部位、EGFR突变、年龄、肿瘤直径、临床N分期、巩固化疗和放疗剂量。
- 5折嵌套交叉验证的平均AUC为0.719,优于任何单一因素。
- 校准曲线显示预测远处失败率与实际观察值一致性满意。
- DCA显示该模型大多数阈值概率具有良好净获益。
临床怎么用
- 该列线图可用于辅助预测LA-NSCLC根治性放化疗后的首次失败模式,帮助临床医生识别局部或远处失败风险较高的患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To analyze patterns of failure in patients with LA-NSCLC who received definitive chemoradiotherapy (CRT) and to build a nomogram for predicting the failure patterns in this population of patients. MATERIALS AND METHODS: Clinicopathological data of patients with LA-NSCLC who received definitive chemoradiotherapy and follow-up between 2013 and 2016 in our hospital were collected. The endpoint was the first failure after definitive chemoradiotherapy. With using elastic net regression and 5-fold nested cross-validation, the optimal model with better generalization ability was selected. Based on the selected model and corresponding features, a nomogram prediction model was built. This model was also validated by ROC curves, calibration curve and decision curve analysis (DCA). RESULTS: With a median follow-up of 28 months, 100 patients experienced failure. There were 46 and 54 patients who experience local failure and distant failure, respectively. Predictive model including 9 factors (smoking, pathology, location, EGFR mutation, age, tumor diameter, clinical N stage, consolidation chemotherapy and radiation dose) was finally built with the best performance. The average area under the ROC curve (AUC) with 5-fold nested cross-validation was 0.719, which was better than any factors alone. The calibration curve revealed a satisfactory consistency between the predicted distant failure rates and the actual observations. DCA showed most of the threshold probabilities in this model were with good net benefits. CONCLUSION: Clinicopathological factors could collaboratively predict failure patterns in patients with LA-NSCLC who are receiving definitive chemoradiotherapy. A nomogram was built and validated based on these factors, showing a potential predictive value in clinical practice.
引用
- Zhu X, Hou R, Li X, et al. Predictive model of the first failure pattern in patients receiving definitive chemoradiotherapy for inoperable locally advanced non-small cell lung cancer (LA-NSCLC). Radiat Oncol. 2020. PMID: 32070383. doi:10.1186/s13014-020-1467-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。